Atlas Trials

Advanced Non-squamous Non-small-cell Lung Cancer

14 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Advanced Non-squamous Non-small-cell Lung Cancer

RecordFirmDate
A Study of TQB2450 Injection Plus Chemotherapy Followed by TQB2450 Plus Anlotinib Versus Tislelizumab Plus Chemotherapy Followed by Tislelizumab in the Treatment of First-line Non-squamous Non-small Cell Lung Cancer(NSCLC). (NCT05346952)Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2022-01-25
First-Line Treatment for Advanced Non-squamous Non-Small-Cell Lung Cancer With Negative Driver Gene: a Single-center, Single-Arm Trial (NCT05648071)Qianfoshan Hospital2021-12-01
Efficacy and Safety of Use of Platinum Based Doublet Chemotherapy Plus Antiangiogenesis and Immune Checkpoint Inhibitors in Patients With Advanced Non-squamous Non-small Cell Lung Cancer (NCT04137588)Peking University Cancer Hospital & Institute2021-03-03
A Study to Compare the Similarity in Efficacy and Safety Between TRS003 and China-approved Bevacizumab® in NSCLC (NCT04416035)Zhejiang Teruisi Pharmaceutical Inc.2020-08-17
Pemetrexed Plus Apatinib Maintenance Treatment in Patients With Non-squamous Non-small Cell Lung Cancer Patients Who Have Not Progressed After 4 Cycles of Induction Chemotherapy of Pemetrexed in Combination With Platinum-based Regimen (NCT03792503)Xinqiao Hospital of Chongqing2019-02-01
Efficacy and Safety of Maintenance Apatinib Combined With Pemetrexed in Advanced Non-squamous Non-small Cell Lung Cancer Patients (NCT03190239)Xinqiao Hospital of Chongqing2017-07-15
Dose Escalation of Bevacizumab With Ambulatory Blood Pressure Monitoring in Patients With Advanced Non-squamous NSCLC (NCT01063283)University of Chicago2010-03-01
Influence of Prior Chemotherapy on Clinical Benefit With Erlotinib in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer With or Without EGFR Gene Mutation (NCT01204307)Chang Gung Memorial Hospital2010-01-01

Track Advanced Non-squamous Non-small-cell Lung Cancer automatically

Every clearance here is in the API, with alerts when new ones post.